April 30 /PRNewswire/ -- BioTransplant Incorporated (Nasdaq: BTRN - news) announced that it has adjourned today's special meeting of stockholders. The meeting, which was adjourned because a quorum was not present, will reconvene on May 2, 2001 at 10:00 a.m., local time at Hale and Dorr LLP, 60 State Street, Boston, Massachusetts.
The special meeting of stockholders is for the purpose of voting on a proposal to approve the issuance of shares of the Company's common stock to security holders of Eligix, Inc., as contemplated by the agreement and plan of merger entered into by BioTransplant and Eligix on December 8, 2000. The Company will keep the polls open for voting on the proposal until votes are taken at the reconvened meeting. Shareholders are encouraged to submit proxies or otherwise vote their shares, to the extent they have not already done so.
BioTransplant also announced today that Eligix received a proposed term sheet from a large publicly-traded health care company for European distribution of its B-Cell HDM product, which is presently CE mark approved, and its other high density microparticle products under development. Execution of the term sheet and any definitive agreement is subject to, among other things, negotiation of the key terms of the distribution arrangement, satisfactory due diligence and approval by each party's board of directors... |
